ViroCell Biologics a cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) specializing in GMP viral vector manufacturing for clinical trials, has signed a five-year Master Services Agreement (MSA) with a prominent U.S. NCI-designated cancer center. Under the MSA, the cancer center will have access to ViroCell’s full range of pre-clinical and clinical viral vector services to accelerate its clinical development of novel gene-modified cell therapies. Pre-clini...